Pregled bibliografske jedinice broj: 811704
Practical guidance for cervical dystonia management involving botulinum toxin: a consensus statement
Practical guidance for cervical dystonia management involving botulinum toxin: a consensus statement // Journal of neurology, 262 (2015), 10; 1-13 doi:10.1007/s00415-015-7703-x (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 811704 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Practical guidance for cervical dystonia management
involving botulinum toxin: a consensus statement
Autori
Albanese, A. ; Abbruzze, G. ; Dressler, D. ; Marti, M.J. ; Monteccucco, C. ; Moro, E. ; Relja, Maja ; Roze, E. ; Skogseid, I.M. ; Timbareva, S. ; Tsoulis, C.
Izvornik
Journal of neurology (0340-5354) 262
(2015), 10;
1-13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Cervical dystonia ; botulinum toxin ; therapy
Sažetak
Cervical dystonia is a neurological movement disorder causing abnormal posture of the head. It may be accompanied by involuntary movements which are sometimes tremulous. The condition has marked effects on patients' self-image, and adversely affects quality of life, social relationships and employment. Botulinum neurotoxin (BoNT) is the treatment of choice for CD and its efficacy and safety have been extensively studied in clinical trials. However, current guidelines do not provide enough practical information for physicians who wish to use this valuable treatment in a real-life setting. In addition, patients and physicians may have different perceptions of what successful treatment outcomes should be. Consequently, an international group of expert neurologists, experienced in BoNT treatment, met to review the literature and pool their extensive clinical experience to give practical guidance about treatment of CD with BoNT. Eight topic headings were considered: the place of BoNT within CD treatment options ; patient perspectives and desires for treatment ; assessment and goal setting ; starting treatment with BoNT-A ; follow- up sessions ; management of side effects ; management of non- response ; switching between different BoNT products. One rapporteur took responsibility for summarising the current literature for each topic, while the consensus statements were developed by the entire expert group. These statements are presented here along with a discussion of the background information.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2014-09-4503 - Klostridijski neurotoksini i mozak (BrainTox) (Lackovic, Zdravko, HRZZ - 2014-09) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Maja Relja
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus
- PubMed